Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia

BACKGROUND: Botulinum neurotoxin type A (BoNT-A) is an effective pharmacological treatment for the management of cervical dystonia (CD) that requires repeated administration at variable intervals. We explored patient perceptions of the impact of CD and the waning of BoNT-A therapeutic effects. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Comella, Cynthia, Ferreira, Joaquim J., Pain, Emilie, Azoulai, Marion, Om, Savary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914227/
https://www.ncbi.nlm.nih.gov/pubmed/32939574
http://dx.doi.org/10.1007/s00415-020-10217-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914227/
https://www.ncbi.nlm.nih.gov/pubmed/32939574
http://dx.doi.org/10.1007/s00415-020-10217-7

Ejemplares similares